about
Tandem Aldol-Michael reactions in aqueous diethylamine medium: a greener and efficient approach to dimedone-barbituric acid derivatives.A greener, efficient approach to Michael addition of barbituric acid to nitroalkene in aqueous diethylamine medium.(1E,4E)-1,5-Bis[4-(di-ethyl-amino)-phen-yl]penta-1,4-dien-3-one.Sickle cell disease in Saudi Arabia: the phenotype in adults with the Arab-Indian haplotype is not benign.6-[(2-Methyl-phen-yl)sulfan-yl]-5-propyl-pyrimidine-2,4(1H,3H)-dione.3-(Adamantan-1-yl)-4-benzyl-1H-1,2,4-triazole-5(4H)-thione.Crystal structure of 6-chloro-5-iso-propyl-pyrimidine-2,4(1H,3H)-dioneCrystal structure of 2-(adamantan-1-yl)-5-(4-bromo-phen-yl)-1,3,4-oxa-diazole.Crystal structure of cyclo-hexyl-ammonium thio-cyanate.Crystal structure of 3-[(4-benzyl-piperazin-1-yl)meth-yl]-5-(thio-phen-2-yl)-2,3-di-hydro-1,3,4-oxa-diazole-2-thione.N-Phenyl-2-(propan-2-yl-idene)-hydrazine-carboxamide.(1Z,2E)-N'-{2-Chloro-1-methyl-2-[2-(4-methyl-phen-yl)hydrazin-1-yl-idene]ethyl-idene}-4-meth-oxy-benzohydrazide(E)-N'-(4-Isopropyl-benzyl-idene)isonicotinohydrazide monohydrate(E)-4-Amino-N-(1,2-dihydro-pyridin-2-yl-idene)benzene-sulfonamide nitro-methane monosolvate.6-(3,5-Dimethyl-benz-yl)-5-ethyl-1-[(2-phenyl-eth-oxy)meth-yl]pyrimidine-2,4(1H,3H)dione1-(4-Methyl-phen-yl)-2-(phenyl-sulfon-yl)ethanone.3-Chloro-4-methyl-quinolin-2(1H)-one3-Acetyl-1,5-diphenyl-1H-pyrazole-4-carbonitrile.(E)-2-(2,3-Dimethyl-anilino)-N'-[2-methyl-5-(prop-1-en-2-yl)cyclo-hex-2-enyl-idene]benzohydrazide(Z)-3-p-Tolyl-2-(p-tolyl-imino)-1,3-thia-zolidin-4-oneN'-[(1E,2E)-3,7-Dimethyl-octa-2,6-dien-1-yl-idene]pyridine-4-carbohydrazide.3-Acetyl-5-phenyl-1-p-tolyl-1H-pyrazole-4-carbonitrile.3-Methyl-1-benzofuran-2-carbohydrazide.(E)-3-Anilino-2-benzoyl-3-(methyl-sulfan-yl)acrylonitrile.3-[(N-Methyl-anilino)meth-yl]-5-(thio-phen-2-yl)-1,3,4-oxadiazole-2(3H)-thione3-(Adamantan-1-yl)-4-ethyl-1H-1,2,4-triazole-5(4H)-thione.Methyl 2-({6-[(1-meth-oxy-2-methyl-1-oxopropan-2-yl)carbamo-yl]pyridin-2-yl}formamido)-2-methyl-propano-ate.5-Bromo-4-(3,4-dimeth-oxy-phen-yl)thia-zol-2-amine1-(4-Fluoro-phen-yl)-2-(phenyl-sulfon-yl)ethanone.N-[4-(4-Bromo-phen-yl)thia-zol-2-yl]-4-(piperidin-1-yl)butanamide1-(3-Ethyl-phen-yl)-4,6-dimethyl-2-oxo-1,2-dihydro-pyridine-3-carbonitrile1-(5-Bromo-4-phenyl-1,3-thia-zol-2-yl)pyrrolidin-2-one.(E)-2-Cyano-N'-(1,2,3,4-tetra-hydro-naphthalen-1-yl-idene)acetohydrazide.Methyl 2-{6-[(1-meth-oxy-1-oxopropan-2-yl)amino-carbon-yl]pyridine-2-carboxamido}-propano-ate(Z)-2-Benzyl-idenebenzo[d]thia-zolo[3,2-a]imidazol-3(2H)-one(Z)-2-(5-Acetyl-4-methyl-3-phenyl-2,3-dihydro-1,3-thia-zol-2-yl-idene)-3-(3-methyl-1-benzofuran-2-yl)-3-oxo-propane-nitrile.Synthesis, Crystal Study, and Anti-Proliferative Activity of Some 2-Benzimidazolylthioacetophenones towards Triple-Negative Breast Cancer MDA-MB-468 Cells as Apoptosis-Inducing Agents.5-Propyl-6-(p-tolyl-sulfan-yl)pyrimidine-2,4(1H,3H)-dione.4-(2-Meth-oxy-phen-yl)piperazin-1-ium 6-chloro-5-isopropyl-2,4-dioxopyrimidin-1-ideSynthesis, molecular structure and spectroscopic investigations of novel fluorinated spiro heterocycles.
P50
Q30392302-BBD728F6-5D1A-4E31-AF0A-4F29D5A1D4EEQ30738527-5C5FFF0A-43AC-4D6F-824C-F08E760F13A1Q33571181-8C2B29F5-281E-4DDA-B260-EE5B9F01228BQ33888761-8C19ADC6-EF56-47EF-A25C-981A426BF4EEQ33996950-AE9D25E2-519D-44A1-9795-385A397DEF28Q33997167-3152A7CF-DBC0-49C7-AEF2-98B8CBD87B3CQ34638478-A2B57E28-2229-490E-B5C7-1B22BE78F06FQ34638958-A634A64A-49C6-46B6-ACF8-8D4788C591DCQ35093462-822563B6-EA82-4D20-8654-AC073B85A3B8Q35150887-94B42647-7335-421B-8498-EDE54E16091EQ35808112-82A8944A-E56D-40A0-9B7A-2506E77E2CBBQ35932963-4400C961-AAE0-43D7-B49C-A5902663BD0CQ35933169-79E6D4C8-01DB-4170-9C19-BAC825303AE3Q35933238-22AC9848-4A63-4C5B-9542-8942CCF6D023Q35933242-A61FDB2B-A787-4853-BB1F-60A2DEAA5190Q35933247-3143EC99-BEC1-4A8D-B2DB-5737F57CE9AFQ35933284-9B177CCF-4EFE-4F1D-8D41-F87B9ECC2395Q35933392-7435BE09-BB23-43D4-9942-CE08A55743B1Q35933475-4114C68D-B348-4CB8-9385-F38C372A0503Q35933492-0DFEF6C9-3784-434F-B7D3-4E74647923DEQ35933499-FFA57B3C-DB2D-402A-B8F8-C6E61830DBAFQ35933554-85C45383-4298-4ECD-A0BA-67AC3D978126Q35933783-27A952D0-E6C3-4C62-8FFB-094AA6A9CDD0Q35933832-9F4F5494-EC0A-4DFA-9C24-869F3ECE2DFDQ35934546-1776E990-2D18-41D8-9A4F-93A3562D3A0DQ35934551-116EAC5A-E49D-4B82-A4A4-41939ABDFB6FQ35934601-1F40C9EA-324A-433C-9669-174113CA7588Q36046084-F92CF0F0-9E53-4E20-A371-C244DAC7133BQ36046165-DB7AA865-47AC-49A5-978B-1AFB90170BC3Q36046188-EFE5215D-080D-444A-A675-104FB11037ECQ36046242-B347DE80-A7B5-43AC-B028-1ABD7076C06CQ36046439-484A7D34-1AAD-41BD-862A-62ED40B2AED0Q36046447-07C06DCB-A51D-4195-AAEE-F283D37719F5Q36046632-2CF2CC43-984B-474D-BD9B-45E862ECD67DQ36214380-05F995FB-8448-4825-8871-85F30ED441C6Q36214461-CC53A719-3437-41DA-81BA-0B8A2965A00EQ37209905-D30BBD68-07FD-4ADE-95CA-40EFCF366EEDQ37720992-BF12A858-5CD1-40F1-9EC4-5C3DD12BC520Q37721145-07F776F6-E86E-4337-A6D4-73CB0A4E8F55Q38547108-5E70739D-6411-41B7-8460-2350BC8C82AF
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Hazem A Ghabbour
@es
Hazem A. Ghabbour
@en
Hazem A. Ghabbour
@nl
Hazem A. Ghabbour
@sl
type
label
Hazem A Ghabbour
@es
Hazem A. Ghabbour
@en
Hazem A. Ghabbour
@nl
Hazem A. Ghabbour
@sl
prefLabel
Hazem A Ghabbour
@es
Hazem A. Ghabbour
@en
Hazem A. Ghabbour
@nl
Hazem A. Ghabbour
@sl
P1053
B-9334-2012
P106
P1153
54966825400
P1960
DGg6-BsAAAAJ
P2038
Hazem_Ghabbour
P21
P31
P3829
P496
0000-0002-1011-0276
P569
2000-01-01T00:00:00Z